Last reviewed · How we verify
NCT06110234: SPECTRA
Efficacy, Transfer, and Neuro-functional Basis of a Memory Training Targeting Episodic Retrieval in Older Adults.
NA trial testing Episodic Specificity Induction in Healthy in 51 participants. Completed in 29 February 2024.
29 February 2024
Quick facts
| Lead sponsor | Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 51 |
| Start date | 22 September 2023 |
| Primary completion | 29 February 2024 |
| Estimated completion | 29 February 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Episodic Specificity Induction
- Associative Memory
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Who can join
Adults 60 to 85, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aging leads to cognitive changes that affect memory, particularly episodic retrieval. These impairments are detrimental to seniors' quality of life. Cognitive trainings are of great interest to the scientific community because they improve cognition in older people, and produce structural and functional changes likely to provide neuroprotection. Identifying the brain changes induced by cognitive training could therefore provide a better understanding of the neuroplastic processes of the aging brain. Some training programs aim to improve key processes underlying cognitive functioning to lead to transfer, but these most often target working memory or processing speed. Our aim is to understand the brain changes associated with a training program targeting episodic retrieval, and likely to engage a core network for memory, including the anterior hippocampus. 60 healthy older adults will be randomly divided into two groups; one receiving a training based on the Episodic Specificity Induction (ESI) - a manipulation based on a well-established police interviewing technique thought to target and facilitate episodic construction; the other receiving a control training consisting of recalling pairs of words and images. Before and after training, behavioural and brain measures will be taken. Behavioural measures will be taken during recall, recognition, and problem solving tasks. These tasks will be completed once in the ESI condition (after one ESI) and once in the NoESI condition (after a general thoughts interview). Measures of brain activation as well as static and dynamic functional connectivity (SFC \& DFC) will be taken using magnetic resonance imaging (MRI) during a recognition task. For behavioural measures, higher pre-training performance should be observed in the ESI than in the NoESI condition, and pre-to-post-training improvement should be observed only after the ESI training, especially in the NoESI condition. For brain measures, ESI training should decrease activation of the task network targeted by training, reflecting an increase in efficiency. ESI training should also increase the SFC of the task network and reduce its connectivity with the cognitive control network, suggesting more automated processing. Finally, ESI training should increase DFC by increasing the speed of transition between the networks associated with the two phases of episodic retrieval: the construction phase and the elaboration phase.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives.
Yang X, Guo H, Zou M. · · 2026 · cited 2× · PMID 41495287 · DOI 10.1186/s43556-025-00395-z -
Efficacy and transfer of a memory training based on the Episodic Specificity Induction in older adults.
Purkart R, Leblond-Baccichet G, Mellah S, Jägersberg A, et al · · 2026 · PMID 42246234 · DOI 10.1080/09658211.2026.2672008
Verify or expand the search:
- PubMed search for NCT06110234
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal trials
Trials by the same sponsor.
- NCT06888713 — Telemonitoring of Activities of Daily Living in Home Care Services of Older Adults with Cognitive Deficits · NA · not yet recruiting
- NCT07427693 — Usability, Acceptability and Effect of a Mobile Application and Connected Object for Older Women With UI · NA · active not recruiting
- NCT03506672 — Assessing the Effectiveness of an Approach for Vocal Behaviors in Older People Living in Nursing Homes · NA · completed
- NCT03400384 — Trial Applying Policy to Eliminate or Reduce Inappropriate Narcotics in the General-population · NA · completed
- NCT03532113 — Attentional Control Training in Older Adults: Efficacy, Transfer and Brain Substrates · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06110234 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
- Last refreshed: 1 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06110234.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing